264 related articles for article (PubMed ID: 33573312)
1. Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices.
Zaami S; Orrico A; Signore F; Cavaliere AF; Mazzi M; Marinelli E
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33573312
[TBL] [Abstract][Full Text] [Related]
2. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
[TBL] [Abstract][Full Text] [Related]
3. Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec.
Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
BMC Med Ethics; 2020 Feb; 21(1):15. PubMed ID: 32041603
[TBL] [Abstract][Full Text] [Related]
4. Cross-cultural perspectives on decision making regarding noninvasive prenatal testing: A comparative study of Lebanon and Quebec.
Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
AJOB Empir Bioeth; 2018; 9(2):99-111. PubMed ID: 29847254
[TBL] [Abstract][Full Text] [Related]
5. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
[TBL] [Abstract][Full Text] [Related]
6. From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns.
Zhytnik L; Peters M; Tilk K; Simm K; Tõnisson N; Reimand T; Maasalu K; Acharya G; Krjutškov K; Salumets A
Hum Reprod Update; 2021 Oct; 27(6):1056-1085. PubMed ID: 34329448
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues.
Minear MA; Alessi S; Allyse M; Michie M; Chandrasekharan S
Annu Rev Genomics Hum Genet; 2015; 16():369-98. PubMed ID: 26322648
[TBL] [Abstract][Full Text] [Related]
9. Prenatal screening: current practice, new developments, ethical challenges.
de Jong A; Maya I; van Lith JM
Bioethics; 2015 Jan; 29(1):1-8. PubMed ID: 25521968
[TBL] [Abstract][Full Text] [Related]
10. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
11. A qualitative study of women and partners from Lebanon and Quebec regarding an expanded scope of noninvasive prenatal testing.
Haidar H; Le Clerc-Blain J; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
BMC Pregnancy Childbirth; 2021 Jan; 21(1):54. PubMed ID: 33441113
[TBL] [Abstract][Full Text] [Related]
12. The Emergence and Global Spread of Noninvasive Prenatal Testing.
Ravitsky V; Roy MC; Haidar H; Henneman L; Marshall J; Newson AJ; Ngan OMY; Nov-Klaiman T
Annu Rev Genomics Hum Genet; 2021 Aug; 22():309-338. PubMed ID: 33848430
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive prenatal testing: ethics and policy considerations.
Vanstone M; King C; de Vrijer B; Nisker J
J Obstet Gynaecol Can; 2014 Jun; 36(6):515-526. PubMed ID: 24927192
[TBL] [Abstract][Full Text] [Related]
14. Women's perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions.
Vanstone M; Cernat A; Nisker J; Schwartz L
BMC Med Ethics; 2018 Apr; 19(1):27. PubMed ID: 29661182
[TBL] [Abstract][Full Text] [Related]
15. Ethical issues associated with prenatal screening using non-invasive prenatal testing for sex chromosome aneuploidy.
Johnston M; Warton C; Pertile MD; Taylor-Sands M; Delatycki MB; Hui L; Savulescu J; Mills C
Prenat Diagn; 2023 Feb; 43(2):226-234. PubMed ID: 35929376
[TBL] [Abstract][Full Text] [Related]
16. Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy.
Griffin B; Edwards S; Chitty LS; Lewis C
J Psychosom Obstet Gynaecol; 2018 Mar; 39(1):11-18. PubMed ID: 28635528
[TBL] [Abstract][Full Text] [Related]
17. Patient Perceptions on the Advancement of Noninvasive Prenatal Testing for Sickle Cell Disease among Black Women in the United States.
Thomas SP; Fletcher FE; Willard R; Ranson TM; Bonham VL
AJOB Empir Bioeth; 2024; 15(2):154-163. PubMed ID: 38349128
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive prenatal testing (NIPT): societal pressure or freedom of choice? A vignette study of Dutch citizens' attitudes.
Kater-Kuipers A; Bakkeren IM; Riedijk SR; Go ATJI; Polak MG; Galjaard RH; de Beaufort ID; Bunnik EM
Eur J Hum Genet; 2021 Jan; 29(1):2-10. PubMed ID: 32759960
[TBL] [Abstract][Full Text] [Related]
19. Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences.
Cernat A; De Freitas C; Majid U; Trivedi F; Higgins C; Vanstone M
BMC Pregnancy Childbirth; 2019 Jan; 19(1):27. PubMed ID: 30642270
[TBL] [Abstract][Full Text] [Related]
20. Should non-invasive prenatal testing (NIPT) be used for fetal sex determination? Perspectives and experiences of healthcare professionals.
Claesen-Bengtson Z; Bowman-Smart H; Vermeersch E; Vermeesch JR; Henneman L; Borry P
Eur J Hum Genet; 2024 Mar; 32(3):309-316. PubMed ID: 38278868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
